相关实验视频
Updated: Jan 14, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
USP3 通过除化,通过稳定 PLK1 来促进质瘤的进展
Feng Yan1,2,3, Yongzhi Shan1,2,3, Yaming Wang1,2,3
1Department of Neurosurgery, Xuanwu Hospital Capital Medical University, Beijing 100053, China.
USP3二基化酶稳定PLK1,促进质瘤的进展和恶性瘤. 准USP3-PLK1轴为攻击性脑瘤提供了一个潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 质瘤是一种侵略性的脑瘤,需要新的治疗点.
- 在癌症的进展中,ubiquitination和deubiquitination途径至关重要.
- 美国P3 (deubiquitinating酶) 和PLK1 (细胞循环激酶) 与癌症扩散有关.
研究的目的:
- 为了研究USP3是否通过duebiquitination调节PLK1,从而影响质瘤的进展.
- 为了分析质瘤组织中USP3的表达.
- 确定USP3,PLK1和质瘤恶性之间的机制联系.
主要方法:
- 用于USP3表达式分析的TCGA数据集.
- 获得功能的 (USP3过度表达) 和失去功能的 (USP3敲击) 细胞模型.
- 细胞增殖 (CCK-8),细胞循环 (流细胞计),迁移/入侵 (Transwell) 的测试.
- 裸体老鼠异种移植和PCNA免疫组织化学.
- 共同免疫沉和西部斑点测试以评估蛋白质相互作用和无处不在.
主要成果:
- 在质瘤组织中,USP3被上调调节.
- USP3过度表达增加了质瘤细胞的增殖,细胞周期的进展和入侵.
- 通过USP3的淘汰,这些恶性表型被抑制了.
- USP3通过减少K48链接的泛化,使PLK1脱化和稳定.
- USP3的淘汰增加了PLK1的无处不在,并减少了PLK1的丰度.
- 瘤异种移植显示出增加的生长和PCNA水平与USP3过度表达,和减少的生长与淘汰.
结论:
- USP3通过使PLK1.1脱化和稳定,促进结质瘤恶性病变.
- 这种稳定增强了质瘤细胞的扩散和入侵.
- USP3-PLK1轴代表了质瘤治疗的潜在治疗点.
更多相关视频
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
12:52Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
相关概念视频
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
Negative Regulator Molecules
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The JAK-STAT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...